ReviewBrain & spine2026
The use of SPECT-CT in the evaluation of lumbar spine pathology - A Narrative Review.
Review in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic low back pain is frequently associated with multilevel degenerative abnormalities that may not identify the symptomatic structure. Single-photon emission computed tomography combined with computed tomography (SPECT-CT) combines metabolic and anatomical imaging and has been proposed as an adjunct where conventional imaging is inconclusive. Research question: To critically assess current evidence concerning the diagnostic and clinical utility of SPECT-CT in lumbar degenerative pathology. Materials and methods: PubMed was searched for English-language publications dated from 2000 to 2025 concerning SPECT-CT, lumbar pathology and low back pain. Primary clinical studies, technical studies, relevant reviews and guidelines were synthesised narratively, with direct and contextual evidence distinguished. Results: The evidence base is heterogeneous and predominantly observational. SPECT-CT can anatomically localize sites of increased osseous tracer uptake and may provide additional information in selected diagnostically challenging cases. However, interpretation is limited by non-standardised positivity thresholds, interobserver variability, discordance with MRI, imperfect agreement with diagnostic blocks, absence of a validated reference standard and limited controlled evidence that SPECT-CT-guided management improves outcomes. Discussion and conclusion: SPECT-CT may have an adjunctive role in carefully selected patients with unresolved diagnostic uncertainty where the result is likely to alter management. Current evidence is insufficient to support routine use or to conclude that SPECT-CT independently identifies the true pain source, improves treatment selection or improves outcomes over conventional diagnostic pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.